AIM insider transaction filings
AIM ImmunoTech Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-18. Screen AIM transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 4 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 4 filings by 1 insider — 62,900 shares, $13,456 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 24,000 shares @ $0.21 ($4,992) by Equels Thomas K, filed 2026-09-18.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Equels Thomas K — CEO & President, Director | 4 | 4 legs · 62,900 sh · $13,456 | — | — |
Recent Form 4 filings — AIM ImmunoTech Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 24,000 @ $0.21 | EDGAR |
| 2026-09-17 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 11,000 @ $0.21 | EDGAR |
| 2026-09-16 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 22,000 @ $0.22 | EDGAR |
| 2026-09-15 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 5,900 @ $0.22 | EDGAR |
| 2026-03-16 | 4 | Equels Thomas K — CEO & President, Director | Conversion (C): 25,000 @ $0 · Conversion (C): 25 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | CHEMEROW DAVID I. — Director | Conversion (C): 25,000 @ $0 · Conversion (C): 25 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | Equels Thomas K — CEO & President | Other (J): 25 (derivative) @ $25,000 · Other (J): 50,000 (derivative) @ $0 | EDGAR |
| 2026-03-10 | 4 | CHEMEROW DAVID I. — Director | Other (J): 25 (derivative) @ $25,000 · Other (J): 50,000 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | CHEMEROW DAVID I. — Director | Grant/award (A): 2,800 @ $1.23 | EDGAR |
| 2025-07-21 | 4 | KELLNER TED D — Director | Holdings only — no transactions reported | EDGAR |
| 2025-06-16 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 107 @ $7.70 | EDGAR |
| 2025-06-13 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 103 @ $8.70 | EDGAR |
| 2025-04-23 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 1,968,504 @ $0.03 | EDGAR |
| 2025-04-23 | 4 | MITCHELL WILLIAM M — Director | Purchase (P): 196,851 @ $0.03 | EDGAR |
| 2025-04-23 | 4 | KELLNER TED D — Director | Purchase (P): 1,968,504 @ $0.03 | EDGAR |
| 2025-04-07 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 41,000 @ $0.06 | EDGAR |
| 2025-04-04 | 4 | Rodino Peter W III — COO, Secretary, Gen. Counsel | Purchase (P): 500 @ $0.09 | EDGAR |
| 2025-03-18 | 4 | BRYAN NANCY — Director | Grant/award (A): 44,899 @ $0.12 | EDGAR |
| 2025-03-18 | 4 | CHEMEROW DAVID I. — Director | Grant/award (A): 44,899 @ $0.12 | EDGAR |
| 2025-03-18 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 44,899 @ $0.12 | EDGAR |
| 2025-03-06 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 50,000 @ $0.13 | EDGAR |
| 2025-03-05 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 44,000 @ $0.12 | EDGAR |
| 2025-03-04 | 4 | BRYAN NANCY — Director | Grant/award (A): 38,580 @ $0.14 | EDGAR |
| 2025-03-04 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 83,334 @ $0.12 | EDGAR |
| 2025-03-04 | 4 | CHEMEROW DAVID I. — Director | Grant/award (A): 19,290 @ $0.14 | EDGAR |
| 2025-03-04 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 38,580 @ $0.14 | EDGAR |
| 2025-02-20 | 4/A | MITCHELL WILLIAM M — Director | Grant/award (A): 43,330 @ $0.12 | EDGAR |
| 2025-02-20 | 4/A | MITCHELL WILLIAM M — Director | Grant/award (A): 25,797 @ $0.20 | EDGAR |
| 2025-02-20 | 4/A | MITCHELL WILLIAM M — Director | Grant/award (A): 27,412 @ $0.19 | EDGAR |
| 2025-02-19 | 4 | BRYAN NANCY — Director | Grant/award (A): 43,330 @ $0.12 | EDGAR |
| 2025-02-19 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 43,330 @ $0.12 | EDGAR |
| 2025-02-03 | 4 | BRYAN NANCY — Director | Grant/award (A): 25,797 @ $0.20 | EDGAR |
| 2025-02-03 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 25,797 @ $0.20 | EDGAR |
| 2025-01-21 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 20,000 @ $0.21 | EDGAR |
| 2025-01-17 | 4 | BRYAN NANCY — Director | Grant/award (A): 27,412 @ $0.19 | EDGAR |
| 2025-01-17 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 27,412 @ $0.19 | EDGAR |
| 2025-01-03 | 4 | APPELROUTH STEWART — Director | Grant/award (A): 8,768 @ $0.20 | EDGAR |
| 2025-01-03 | 4 | BRYAN NANCY — Director | Grant/award (A): 26,305 @ $0.20 | EDGAR |
| 2025-01-03 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 26,305 @ $0.20 | EDGAR |
| 2024-12-20 | 4 | MITCHELL WILLIAM M — Director | Sale (S): 4,580 @ $0.19 | EDGAR |
| 2024-12-19 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 22,727 @ $0.21 | EDGAR |
| 2024-12-17 | 4 | APPELROUTH STEWART — Director | Grant/award (A): 24,452 @ $0.21 | EDGAR |
| 2024-12-17 | 4 | BRYAN NANCY — Director | Grant/award (A): 24,452 @ $0.21 | EDGAR |
| 2024-12-17 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 24,452 @ $0.21 | EDGAR |
| 2024-12-04 | 4 | APPELROUTH STEWART — Director | Purchase (P): 1 @ $0.21 · Purchase (P): 11,111 @ $0.21 | EDGAR |
| 2024-12-03 | 4 | APPELROUTH STEWART — Director | Grant/award (A): 22,645 @ $0.23 | EDGAR |
| 2024-12-03 | 4 | BRYAN NANCY — Director | Grant/award (A): 22,645 @ $0.23 | EDGAR |
| 2024-12-03 | 4 | MITCHELL WILLIAM M — Director | Grant/award (A): 22,645 @ $0.23 | EDGAR |
| 2024-11-21 | 4 | APPELROUTH STEWART — Director | Purchase (P): 81,953 @ $0.19 | EDGAR |
| 2024-11-21 | 4 | Equels Thomas K — CEO & President, Director | Purchase (P): 85,000 @ $0.20 | EDGAR |
Recent 8-K events — AIM ImmunoTech Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement ? 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2026-07-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-15 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AIM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →